| 2KBW | A: | SOLUTION STRUCTURE OF HUMAN MCL-1 COMPLEXED WITH HUMAN BID_BH3 PEPTIDE |
| 2M03 | A: | SOLUTION STRUCTURE OF BCL-XL DETERMINED WITH SELECTIVE ISOTOPE LABELLING OF I,L,V SIDECHAINS |
| 2W3L | A:; B: | CRYSTAL STRUCTURE OF CHIMAERIC BCL2-XL AND PHENYL TETRAHYDROISOQUINOLINE AMIDE COMPLEX |
| 2Y6W | A:; B: | STRUCTURE OF A BCL-W DIMER |
| 2YJ1 | A:; C: | PUMA BH3 FOLDAMER IN COMPLEX WITH BCL-XL |
| 3FDL | A: | BIM BH3 PEPTIDE IN COMPLEX WITH BCL-XL |
| 3FDM | A:; B:; C: | ALPHA/BETA FOLDAMER IN COMPLEX WITH BCL-XL |
| 3INQ | A:; B: | CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH W1191542 |
| 3IO9 | A: | BIML12Y IN COMPLEX WITH MCL-1 |
| 3KJ0 | A: | MCL-1 IN COMPLEX WITH BIM BH3 MUTANT I2DY |
| 3KJ1 | A: | MCL-1 IN COMPLEX WITH BIM BH3 MUTANT I2DA |
| 3KJ2 | A: | MCL-1 IN COMPLEX WITH BIM BH3 MUTANT F4AE |
| 3KZ0 | A:; B: | MCL-1 COMPLEX WITH MCL-1-SPECIFIC SELECTED PEPTIDE |
| 3MK8 | A: | THE MCL-1 BH3 HELIX IS AN EXCLUSIVE MCL-1 INHIBITOR AND APOPTOSIS SENSITIZER |
| 3R85 | A:; B:; C:; D: | CRYSTAL STRUCTURE OF HUMAN SOUL BH3 DOMAIN IN COMPLEX WITH BCL-XL |
| 3WIX | A:; B:; C:; D: | CRYSTAL STRUCTURE OF MCL-1 IN COMPLEX WITH COMPOUND 4 |
| 3WIY | A:; B:; C:; D:; E:; F: | CRYSTAL STRUCTURE OF MCL-1 IN COMPLEX WITH COMPOUND 10 |
| 3ZK6 | A:; B: | CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH INHIBITOR (COMPOUND 2). |
| 3ZLN | A: | CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH INHIBITOR (COMPOUND 3). |
| 3ZLO | A: | CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH INHIBITOR (COMPOUND 6). |
| 3ZLR | A:; B: | CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH INHIBITOR (WEHI-539). 539). |
| 4A1U | A: | CRYSTAL STRUCTURE OF ALPHA-BETA-FOLDAMER 2C IN COMPLEX WITH BCL-XL |
| 4A1W | A:; B:; C:; D: | CRYSTAL STRUCTURE OF ALPHA-BETA FOLDAMER 4C IN COMPLEX WITH BCL-XL |
| 4AQ3 | A:; B:; C:; D:; E:; F: | HUMAN BCL-2 WITH PHENYLACYLSULFONAMIDE INHIBITOR |
| 4C52 | A:; B: | CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH BENZOYLUREA COMPOUND (39B) |
| 4C5D | A:; B: | CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH BENZOYLUREA COMPOUND (42) |
| 4HW2 | A:; B:; C:; D:; E:; F: | DISCOVERY OF POTENT MCL-1 INHIBITORS USING FRAGMENT-BASED METHODS AND STRUCTURE-BASED DESIGN |
| 4HW3 | A:; B:; C:; D:; E:; F:; G:; H:; I:; J:; K:; L: | DISCOVERY OF POTENT MCL-1 INHIBITORS USING FRAGMENT-BASED METHODS AND STRUCTURE-BASED DESIGN |
| 4IEH | A: | CRYSTAL STRUCTURE OF HUMAN BCL-2 IN COMPLEX WITH A SMALL MOLECULE INHIBITOR TARGETING BCL-2 BH3 DOMAIN INTERACTIONS |
| 4OQ5 | A:; B:; C:; D:; E:; F: | CRYSTAL STRUCTURE OF HUMAN MCL-1 BOUND TO INHIBITOR 4-(4-METHYLNAPHTHALEN-1-YL)-2-{[(4-PHENOXYPHENYL)SULFONYL]AMINO}BENZOIC ACID |
| 4OQ6 | A:; B: | CRYSTAL STRUCTURE OF HUMAN MCL-1 BOUND TO INHIBITOR 4-HYDROXY-4'-PROPYLBIPHENYL-3-CARBOXYLIC ACID |
)
)